EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications
EMPOWER: Evaluating the Ability to Reduce Morphine Equivalent Dose for Chronic Pain Patients Receiving Opioid-therapy Through a Web-based E-Health Self-management Program: a Randomized Multi-site Clinical Trial in Primary Care
2 other identifiers
interventional
402
1 country
2
Brief Summary
This is a 10-month internet-based randomized controlled trial to evaluate whether an online chronic pain management program ("E-Health") can assist with reduced opioid reliance in chronic pain patients. About half of the eligible participants will receive access to the E-Health program in addition to their standard chronic pain treatment; the other half will just continue receiving their standard chronic pain treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Feb 2018
Longer than P75 for not_applicable chronic-pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2017
CompletedFirst Posted
Study publicly available on registry
October 12, 2017
CompletedStudy Start
First participant enrolled
February 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2021
CompletedResults Posted
Study results publicly available
September 28, 2023
CompletedSeptember 28, 2023
September 1, 2023
3.7 years
October 6, 2017
August 9, 2023
September 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Decrease in Morphine Equivalent Dose (MED)
Whether (yes/no) there was a ≥15% decrease in MED, between baseline and 10-month post-randomization follow-up.
Baseline and 10 months
Secondary Outcomes (1)
Pain Intensity
Baseline and 10 months
Study Arms (2)
Treatment As Usual
NO INTERVENTIONParticipants randomized to Treatment As Usual will receive treatment for chronic pain as typically provided by their clinician -- they will receive no extra treatment from the study.
E-Health+
EXPERIMENTALParticipants randomized to the E-health+ arm will receive treatment as typically provided by their clinician plus a 4-month subscription to the E-health program, which is an internet based chronic pain program.
Interventions
The Goalistics Chronic Pain Management Program, referred to as the E-health program in EMPOWER, was developed from cognitive, behavioral, interpersonal, and self-management interventions with demonstrated efficacy in traditional face-to-face or group settings. It is patient-centered, having been developed based on substantial input from people with chronic pain and chronic pain professionals.
Eligibility Criteria
You may qualify if:
- Be 25-80 years of age
- Be able to understand the study, and having understood, provide informed consent in English
- Have a daily average prescribed MED ≥ 20 mg over a recent three-month period
- Have a chronic pain-related diagnosis
- Self-report current use of opioid medication(s) to treat pain
- Have a Brief Pain Inventory Pain Intensity score ≥3
- Have internet access and a working email account
You may not qualify if:
- Be anyone who, in the judgment of study staff, would be unlikely to complete the study (e.g., planning to change to a different primary care clinic, have a terminal illness, etc.)
- Be unwilling/unable to complete the WebNeuro assessments
- Be pregnant
- Be a prisoner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Cincinnatilead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
Duke Health
Durham, North Carolina, 27710, United States
UC Health
Cincinnati, Ohio, 45229, United States
Related Publications (1)
Wilson M, Dolor RJ, Lewis D, Regan SL, Vonder Meulen MB, Winhusen TJ. Opioid dose and pain effects of an online pain self-management program to augment usual care in adults with chronic pain: a multisite randomized clinical trial. Pain. 2023 Apr 1;164(4):877-885. doi: 10.1097/j.pain.0000000000002785. Epub 2022 Sep 15.
PMID: 36525381DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- T. John Winhusen, PhD.
- Organization
- University of Cincinnati
Study Officials
- PRINCIPAL INVESTIGATOR
Theresa Winhusen, Ph.D.
University of Cincinnati
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor; Vice Chair and Division Director of Addiction Sciences
Study Record Dates
First Submitted
October 6, 2017
First Posted
October 12, 2017
Study Start
February 5, 2018
Primary Completion
October 31, 2021
Study Completion
October 31, 2021
Last Updated
September 28, 2023
Results First Posted
September 28, 2023
Record last verified: 2023-09